Nathan A. Beaver is a partner and food and drug lawyer with Foley & Lardner LLP, where his practice focuses on the representation of manufacturers whose products and activities are regulated by the Food and Drug Administration (FDA), Drug Enforcement Administration (DEA), and the Federal Trade Commission (FTC). He advises clients on regulatory issues affecting prescription and over-the-counter drug products (including animal drugs), medical devices, dietary supplements, cosmetics, and foods with special emphasis on the strategic considerations involving the approval process and patent and exclusivity issues related to the Hatch-Waxman Act. Mr. Beaver is a member of the firm’s Government & Public Policy and FDA Practices, and the Food & Beverage Industry and Life Sciences Industry Teams.
Mr. Beaver also has significant experience in FDA and Hatch-Waxman cases involving drug approvals, withdrawals and other types of litigation involving FDA regulated products.
Mr. Beaver was named a 2012 BTI Client Service All-Star, one of only 272 attorneys so honored throughout the United States, as a result of unprompted positive feedback from BTI’s interviews with nearly 300 corporate counsel from Fortune 1000 companies. He was also selected for inclusion in The Best Lawyers in America© since 2015 for his work in food and beverage law. In 2015, Mr. Beaver was recognized by The Legal 500 for his work in health care – life sciences.
Mr. Beaver earned his J.D. from Georgetown University Law Center in 1997. He graduated cum laude in 1994 from the University of Arizona with a Bachelor of Arts degree in interdisciplinary studies. Mr. Beaver is admitted to practice in the District of Columbia.
Collaborating With the FDA: What Has Worked and What Hasn't?
2:20 PM - 3:10 PM